---
title: Regulatory risks in the hospital industry
videoId: AX6BDecnwRQ
---

From: [[shankarnath]] <br/> 

The [[healthcare_industry_in_india | healthcare industry in India]] faces significant regulatory risks due to the Indian government's tendency to intervene when issues arise <a class="yt-timestamp" data-t="00:07:13">[00:07:13]</a>. As investors, it's crucial to be aware of these risks, as government actions can swiftly impact hospital revenues and profit margins <a class="yt-timestamp" data-t="00:08:32">[00:08:32]</a>.

## Government Intervention and its Impact

Government interventions often involve price controls and oversight of [[healthcare_industry_in_india | healthcare]] schemes <a class="yt-timestamp" data-t="00:16:39">[00:16:39]</a>.

### Price Caps
A notable example is the 2017 government decision to cap prices for cardiac stents and knee transplants, which led to a reduction of approximately 70% <a class="yt-timestamp" data-t="00:07:22">[00:07:22]</a>. While beneficial for millions of Indians needing these treatments <a class="yt-timestamp" data-t="00:07:29">[00:07:29]</a>, this had a direct negative impact on hospitals' revenues and profit margins <a class="yt-timestamp" data-t="00:07:34">[00:07:34]</a>. The National Pharmaceutical Pricing Authority (NPPA) estimated this measure would save Indian citizens about 1,500 crores annually, indicating a corresponding loss for the hospital industry <a class="yt-timestamp" data-t="00:07:42">[00:07:42]</a>.

### Anti-Competitive Practices
The Competition Commission of India (CCI) actively monitors and penalizes hospitals that compel patients to purchase medicines at inflated prices from in-house pharmacies, especially when the same medicines are available cheaper elsewhere <a class="yt-timestamp" data-t="00:07:55">[00:07:55]</a>. This extends to diagnostic tests, where hospitals might insist on patients redoing tests at their in-house labs despite recent external laboratory results <a class="yt-timestamp" data-t="00:08:13">[00:08:13]</a>.

### Investor Considerations
When assessing [[financial_metrics_for_investing_in_hospital_stocks | financial metrics]] and business models, it's important to consider the potential for regulatory changes that can affect profit margins and revenue streams <a class="yt-timestamp" data-t="00:08:26">[00:08:26]</a>. This forms a crucial part of [[risk_management_in_investing | risk management in investing]] in the hospital sector <a class="yt-timestamp" data-t="00:08:32">[00:08:32]</a>.